Completed PHASE4 INTERVENTIONAL 2-arm NCT00288587

Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

CP0007: Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

Sponsor: NxStage Medical

Interventions IV loop diuretic NxStage System One

Updated 6 times since 2017 Last updated: May 16, 2012 Started: Oct 31, 2003 Primary completion: Sep 30, 2008 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00288587, this PHASE4 trial focuses on CHF and Heart Failure and remains completed. Sponsored by NxStage Medical, it has been updated 6 times since 2003, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NxStage Medical

Data source: NxStage Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States